The prevention and treatment of venous thromboembolism in pregnancy

References

• Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706. PubMed: 16287790.
   PubMed Web of Science ®Google Scholar
• Gherman RB, Goodwin TM, Leung B, et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94(5 Pt 1):730–734. PubMed: 10546719.
   PubMed Web of Science ®Google Scholar
• Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94(4):595–599. PubMed: 10511366.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Lawrenson RA, Nightingale AL, et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108(1):56–60. PubMed: 11213005.
   PubMed Web of Science ®Google Scholar
• James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315. PubMed: 16647915.
   PubMed Web of Science ®Google Scholar
• Andersen BS, Steffensen FH, Sørensen HT, et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium – an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand. 1998;77(2):170–173. PubMed: 9512321.
   PubMed Web of Science ®Google Scholar
• Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a register-based case-control study. Am J Obstet Gynecol. 2008;198(2):233.e1-7. PubMed: 17997389.
   PubMed Web of Science ®Google Scholar
• McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183–1188. PubMed: 9364982.
   PubMed Web of Science ®Google Scholar
• Berg CJ, Atrash HK, Koonin LM, et al. Pregnancy-related mortality in the United States, 1987–1990. Obstet Gynecol. 1996;88(2):161–167. PubMed: 8692494.
   PubMed Web of Science ®Google Scholar
• Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–938. PubMed: 2025141.
   PubMedGoogle Scholar
• Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632–637. PubMed: 18248600.
   PubMed Web of Science ®Google Scholar
• Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100. PubMed: 22118992.
   PubMed Web of Science ®Google Scholar
• Henriksson P, Westerlund E, Wallén H, et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:e8632. PubMed: 23321489.
   PubMed Web of Science ®Google Scholar
• Hansen AT, Kesmodel US, Juul S, et al. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29(3):611–617. PubMed: 24399508.
   PubMed Web of Science ®Google Scholar
• Villani M, Dentali F, Colaizzo D, et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort. BMJ Open. 2015;5(10):e008213. PubMed: 26443651.
   Web of Science ®Google Scholar
• Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–218. PubMed: 19276806.
   PubMed Web of Science ®Google Scholar
• Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J. 1996;41(3):83–86. PubMed: 8807703.
   PubMed Web of Science ®Google Scholar
• Knight M. UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008;115(4):453–461. PubMed: 18201281.
   PubMed Web of Science ®Google Scholar
• Larsen TB, Sørensen HT, Gislum M, et al. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res. 2007;120(4):505–509. PubMed: 17257657.
   PubMed Web of Science ®Google Scholar
• Gerhardt A, Scharf RE, Greer IA, et al. Hereditary risk factors of thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium. Blood. 2016. [ Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest. 1981;12(3):141–154. PubMed: 7239349.
   PubMed Web of Science ®Google Scholar
• Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258–1265. PubMed: 10217099
   PubMed Web of Science ®Google Scholar
• Macklon NS, Greer IA. The deep venous system in the puerperium: an ultrasound study. Br J Obstet Gynaecol. 1997;104(2):198–200. PubMed: 9070138.
   PubMedGoogle Scholar
• Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104(2):191–197. PubMed: 9070137.
   PubMedGoogle Scholar
• Holzgreve W, Carey JC, Hall BD. Warfarin-induced fetal abnormalities. Lancet. 1976;2(7991):914–915. PubMed: 62152.
   PubMed Web of Science ®Google Scholar
• Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet. 1993;45(1):17–21. PubMed: 8418652.
   PubMed Web of Science ®Google Scholar
• Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33(6):1637–1641. PubMed: 10334435.
   PubMed Web of Science ®Google Scholar
• Cotrufo M, De Feo M, De Santo LS, et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol. 2002;99(1):35–40. PubMed: 11777507.
   PubMed Web of Science ®Google Scholar
• Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006;95(6):949–957. PubMed: 16732373.
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Middeldorp S, et al. American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e691S–736S. PubMed: 22315276.
   PubMed Web of Science ®Google Scholar
• Hoeltzenbein M, Beck E, Meixner K, et al. Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol. 2016;105(2):117–126. PubMed: 26195125.
   PubMed Web of Science ®Google Scholar
• Dempfle CE. Minor transplacental passage of fondaparinux in vivo. N Engl J Med. 2004;350(18):1914–1915. PubMed: 15115845.
   PubMed Web of Science ®Google Scholar
• Arya R. How I manage venous thromboembolism in pregnancy. Br J Haematol. 2011;153(6):698–708. PubMed: 21501137.
   PubMed Web of Science ®Google Scholar
• Bates SM, Middeldorp S, Rodger M, et al. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92–128. PubMed: 26780741.
   PubMed Web of Science ®Google Scholar
• Grandone E, Villani M, Tiscia GL. Aspirin and heparin in pregnancy. Expert Opin Pharmacother. 2015;16(12):1793–1803. PubMed: 26155946.
   PubMed Web of Science ®Google Scholar
• Ghidini A. Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenat Diagn. 2014;34(7):649–654. PubMed: 24752745.
   PubMed Web of Science ®Google Scholar
• Dentali F, Grandone E, Rezoagli E, et al. Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection. J Thromb Haemost. 2011;9(12):2503–2506. PubMed: 21985211.
   PubMed Web of Science ®Google Scholar
• Grandone E, Villani M, Tiscia GL, et al. Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience. Plos One. 2014;9(5):e97604. PubMed: 24870449.
   PubMed Web of Science ®Google Scholar
• Grandone E, Villani M, Tiscia GL, et al. Clinical pregnancies and live births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening. Thromb Res. 2014;133(2):168–172. PubMed: 24321417.
   PubMed Web of Science ®Google Scholar
• Grandone E, Villani M, Dentali F, et al. Low-molecular -weight heparin in pregnancies after ART – a retrospective study. Thromb Res. 2014;134(2):336–339. PubMed: 24972844.
   PubMed Web of Science ®Google Scholar
• Bain E, Wilson A, Tooher R, et al. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014;2:CD001689. PubMed: 24519568.
   PubMed Web of Science ®Google Scholar
• McLean KC, Bernstein IM. Brummel-Ziedins KE. Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol. 2012;207(2):135.e1-6. PubMed: 22840726.
   PubMed Web of Science ®Google Scholar
• Dargaud Y, Hierso S, Rugeri L, et al. Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy. Thromb Haemost. 2010;103(2):469–471. PubMed: 20024504.
   PubMed Web of Science ®Google Scholar
• James A. Committee on practice bulletins – obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011;118(3):718–729. PubMed: 21860313.
   PubMed Web of Science ®Google Scholar
• Chan WS, Rey E, Kent NE. VTE in Pregnancy Guideline Working Group; Society of Obstetricians and Gynecologists of Canada. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527–553. PubMed: 24927193.
   PubMedGoogle Scholar
• Royal College of Obstetricians and Gynaecologists 2015. Green-top Guideline No. 37b. Thromboembolic disease in pregnancy and the puerperium: acute management. cited 2015 Jun 10. Available from:https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37b/.
   Google Scholar
• Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401–407. PubMed: 15811953.
   PubMed Web of Science ®Google Scholar
• Romualdi E, Dentali F, Rancan E, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2013;11(2):270–281. PubMed: 23205953.
   PubMed Web of Science ®Google Scholar
• Roeters van Lennep JE, Meijer E, Klumper FJ, et al. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective? J. Thromb Haemost. 2011;9(3):473–480. PubMed: 21232006.
   Web of Science ®Google Scholar
• Galambosi PJ, Ulander VM, Kaaja RJ. The incidence and risk factors of recurrent venous thromboembolism during pregnancy. Thromb Res. 2014;134(2):240–245. PubMed: 24835671.
   PubMed Web of Science ®Google Scholar
• McLintock C, Brighton T, Chunilal S, et al. Councils of the Society of Obstetric Medicine of Australia and New Zealand; Australasian Society of Thrombosis and Haemostasis. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period. Aust N Z J Obstet Gynaecol. 2012;52(1):14–22. PubMed: 21972999.
   PubMedGoogle Scholar
• Kearon C, Akl EA, Comerota AJ, et al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2Suppl):e419S–94S. PubMed: 22315268.
   PubMed Web of Science ®Google Scholar
• Linkins LA, Dans AL, Moores LK, et al. American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2Suppl):e495S–530S. PubMed: 22315270.
   PubMed Web of Science ®Google Scholar
• Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol. 2004;191(3):1024–1029. PubMed: 15467584.
   PubMed Web of Science ®Google Scholar
• Jacobsen AF, Qvigstad E, Sandset PM. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG. 2003;110(2):139–144. PubMed: 12618157.
   PubMed Web of Science ®Google Scholar
• Crowther MA, Spitzer K, Julian J, et al. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study. Thromb Res. 2000;98(2):133–138. PubMed: 10713314.
   PubMed Web of Science ®Google Scholar
• Rodie VA, Thomson AJ, Stewart FM, et al. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG. 2002;109(9):1020–1024. PubMed: 12269676.
   PubMed Web of Science ®Google Scholar
• Rey E, Rivard GE. Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin. Int J Gynaecol Obstet. 2000;71(1):19–24. PubMed: 11044537.
   PubMed Web of Science ®Google Scholar
• Smith MP, Norris LA, Steer PJ, et al. Tinzaparin sodium for thrombosis treatment and prevention during pregnancy. Am J Obstet Gynecol. 2004;190(2):495–501. PubMed: 14981396.
   PubMed Web of Science ®Google Scholar
• Patel JP, Green B, Patel RK, et al. Population pharmacokinetics of enoxaparin during the antenatal period. Circulation. 2013;128(13):1462–1469. PubMed: 23940396.
   PubMed Web of Science ®Google Scholar
• Nelson-Piercy C, Powrie R, Borg JY, et al. Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile. Eur J Obstet Gynecol Reprod Biol. 2011;159(2):293–299. PubMed: 21945573.
   PubMed Web of Science ®Google Scholar
• Voke J, Keidan J, Pavord S, et al. British society for haematology obstetric haematology group. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Br J Haematol. 2007;39(4):545–558. PubMed: 17916101.
   Web of Science ®Google Scholar